Diagnosis and Management of Multiple Myeloma-Reference-Cited by-同舟云学术

Diagnosis and Management of Multiple Myeloma

Published:2022-02-01 Issue:5 Volume:327 Page:464
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Cowan Andrew J.¹²³,Green Damian J.¹²³,Kwok Mary³⁴,Lee Sarah¹²³,Coffey David G.⁵,Holmberg Leona A.¹²³,Tuazon Sherilyn²⁶,Gopal Ajay K.¹²³,Libby Edward N.¹²³

Affiliation:

1. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle

2. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

3. Seattle Cancer Care Alliance, Seattle, Washington

4. Division of Hematology, Department of Medicine, University of Washington, Seattle

5. Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida

6. Now with Bristol Myers Squibb, Seattle, Washington

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2788522/jama_cowan_2022_rv_220001_1643052314.91932.pdf

Reference113 articles.

1. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020

2. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019.;Zhou;BMC Cancer,2021

3. Cancer risk among firefighters: a review and meta-analysis of 32 studies.;LeMasters;J Occup Environ Med,2006

4. Young adult and usual adult body mass index and multiple myeloma risk: a pooled analysis in the International Multiple Myeloma Consortium (IMMC).;Birmann;Cancer Epidemiol Biomarkers Prev,2017

5. Dioxin exposure and cancer risk: a 15-year mortality study after the “Seveso accident”.;Bertazzi;Epidemiology,1997

Cited by 463 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigallocatechin gallate induces apoptosis in multiple myeloma cells through endoplasmic reticulum stress induction and cytoskeletal disruption;International Immunopharmacology;2024-11

2. Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets;Cell Death & Disease;2024-09-14

3. Interactions between kisspeptin and bone: Cellular mechanisms, clinical evidence, and future potential;Annals of the New York Academy of Sciences;2024-09-13

4. Updates on CAR T cell therapy in multiple myeloma;Biomarker Research;2024-09-12

5. Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-11